小鼠凝血因子VIII免疫应答中的滤泡辅助性T细胞/滤泡调节性T细胞通路
本研究在小鼠中探讨滤泡辅助性T细胞(TFH)与滤泡调节性T细胞(TFR)在凝血因子VIII(FVIII)抑制物产生中的作用。FVIII免疫后,产生抑制物的小鼠脾脏TFR细胞显著增多且TFH/TFR比值升高,TFR细胞缺失使FVIII抑制物滴度显著降低(24 ± 16 vs 131 ± 114 BU/mL),而TFR细胞增多则抑制物滴度更低(8.1 ± 8.6 BU/mL),TFH和TFR均缺失的小鼠未产生抑制物。
要点
- FVIII免疫使产生抑制物的小鼠脾脏TFR细胞显著增加,TFH/TFR比值显著升高。
- TFR细胞缺失小鼠FVIII抑制物滴度显著低于野生型(24 ± 16 vs 131 ± 114 BU/mL),但总抗FVIII IgG无显著差异。
- TFR细胞增多小鼠FVIII抑制物滴度显著低于野生型(8.1 ± 8.6 BU/mL),TFH和TFR均缺失小鼠未产生抑制物。
核心结论
- FVIII免疫诱导TFR细胞活化与扩增,TFR细胞对FVIII抑制物产生具有双重调节作用,TFH/TFR通路在小鼠FVIII抑制物形成中起关键作用。
研究设计与样本
- 研究采用FVIII免疫的小鼠模型,比较产生抑制物与不产生抑制物的FVIIInull小鼠及盐水对照的TFR细胞与TFH/TFR比值。
- 使用TFR缺陷的Foxp3Cre+Bcl6fl/fl(Bcl6FC)小鼠、Foxp3+细胞中Pten缺陷的Foxp3Cre+Ptenfl/fl小鼠及TFH和TFR均缺陷的CD4Cre+Bcl6fl/fl小鼠进行功能验证。
主要发现
- FVIII免疫后产生抑制物的小鼠脾脏TFR细胞较盐水对照及不产生抑制物动物显著增加,TFH/TFR比值显著升高,TFR细胞出现与FVIII抑制物滴度相关。
- Bcl6FC小鼠FVIII免疫后抑制物滴度为24 ± 16 BU/mL,显著低于野生型的131 ± 114 BU/mL,但总抗FVIII IgG水平无显著差异,TFR细胞调节IgG亚类转换和FVIII特异性B细胞应答。
- Foxp3Cre+Ptenfl/fl小鼠FVIII免疫后抑制物滴度为8.1 ± 8.6 BU/mL,显著低于野生型对照。
- CD4Cre+Bcl6fl/fl小鼠FVIII免疫后均未产生FVIII抑制物。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Developing anti-factor VIII (FVIII) inhibitory antibodies (inhibitors) are a significant complication of FVIII protein replacement therapy in hemophilia A. Our previous study demonstrated that follicular helper T (TFH) cells play a critical role in FVIII inhibitor development. Follicular regulatory T (TFR) cells are a subset of forkhead box protein P3 positive (Foxp3+) T cells identified in the germinal center that can modulate TFH cell activation of B cells and antibody development. Here, we report that FVIII immunization significantly increases the TFR cells in the spleens of FVIII inhibitor-producing FVIIInull mice compared with saline-treated controls and non-inhibitor-producing animals. The TFH/TFR ratio significantly increased in FVIII inhibitor-producing mice. The emergence of TFR cells correlated with titers of FVIII inhibitors in FVIII-immunized mice. Using TFR-deficient Foxp3Cre+Bcl6fl/fl (Bcl6FC) mice, we found that the loss of TFR cells led to significantly decreased FVIII inhibitors compared with wild-type (WT) mice on FVIII immunization (24 ± 16 and 131 ± 114 Bethesda unit (BU)/mL, respectively) but not total anti-FVIII IgG levels and that TFR cells regulated IgG subclass switching and FVIII-specific B-cell responses. Interestingly, on FVIII immunization, mice with phosphatase and tensin (Pten) deficiency in Foxp3+ cells (Foxp3Cre+Ptenfl/fl), a model with augmented TFR cells, developed markedly lower FVIII inhibitor titers (8.1 ± 8.6 BU/mL) than WT controls. When CD4Cre+Bcl6fl/fl mice, a TFH- and TFR-deficient model, were immunized with FVIII, none of the animals developed FVIII inhibitors. In conclusion, FVIII immunization induces TFR cell activation and expansion. TFR cells have a dual function in regulating the development of FVIII inhibitors, and the TFH/TFR pathway is pivotal in FVIII inhibitor development in mice.
引用
- Jing W, Schroeder JA, Kumar S, et al. The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice. Blood. 2025. PMID: 40493881. doi:10.1182/blood.2025029470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。